Home > InnoMat.Life final conference
Innomatlife Projekt Logo

InnoMat.Life final conference

From Nano- to Advanced Materials: Lessons learnt in InnoMat.Life

27. – 28.06.2022, Berlin, Germany

This conference addresses stakeholders from policy, science, industry and NGOs who are dealing with regulatory implications of innovative materials in the context of chemical safety. InnoMat.Life will present the final project outcomes and aims to discuss them in a broader context of other ongoing initiatives.

For further informationen please see:

Programme (PDF)

If you wish to present a poster, please use this online form to submit your abstract:


Save the date: Particle Based Materials Symposium 2022 – Enhancing Sustainability 6.-7.10.22

The goal of the Particle Based Materials Symposium is to bring together scientists and engineers from different communities that all share the goal of creating functionality in materials using particles. The synthesis, processing and materials integration of particles into thin films, bulk matrices, fibers or other geometries are covered by this symposium.

Particles and particle-based materials (PBM) are everywhere and will play a crucial role to enhance sustainability of processes and products. The PBM Symposium 2022 thus particularly welcomes contributions dealing with PBM in fields such as energy (generation, storage, transformation), catalysis, recycling, purification and recovery, extension of materials lifetime or damage indication. Besides this, fundamental contributions to better understand the formation or the properties of complex particle systems are very welcome as well.

Deadline for abstract submission juni 01 2022
Deadline for registration August 15 2022

Further informationen:


FDA Publishes Final Guidance for Industry on Nanomaterials in Drug Products

The U.S. Food and Drug Administration (FDA) has published the final guidance document for industry “Drug Products, Including Biological Products, that Contain Nanomaterials” . FDA states that the guidance applies broad array of FDA-regulated products such as human drug products, including those that are biological products, in which a nanomaterial is present in the finished dosage form. The guidance discusses both general principles and specific considerations for developing drug products containing nanomaterials through abbreviated pathways, as well as considerations for quality, nonclinical, and clinical studies as they relate to drug products containing nanomaterials throughout product development and production.

M.ERA-Net Call 2022 launched – Submit your Proposals now

On 15 March 2022, the current M.ERA-Net call for proposals 2022 was published. More than 30 funding organisations are participating with a total budget of around 25 million euros. The deadline for the submission of pre-proposals is 15 June 2022.

The Call 2022 includes the following thematic areas:

  • Materials for energy
  • Innovative surfaces, coatings and interfaces
  • High performance composites
  • Functional materials
  • New strategies for advanced material-based technologies in health applications
  • Materials for electronics

The transnational projects funded by M-ERA.NET are expected to contribute to clean energy-related applications and battery technologies by improving the efficiency of production processes, reducing the usage of materials and energy resources and by improving materials properties such as durability. New approaches to health applications with the focus on advanced materials and coatings will also be addressed. As a new topic, materials for electronics is included.



  • 15.06.2022 – Submission Pre-Proposals
  • 17.11.2022 – Submission Full proposals

EUON Opinion on nanoplastics and the challenges of environmental risk assessment

Our DaNa colleague Dana Kühnel from UFZ Leipzig recently published together with Anita Jemec Kokalj from University of Ljubljana an opinion in the Nanopinion section of the EUONAre nanoplastics hazardous? The way forward to overcome the uncertainties of risk assessment. The scientists explain what criteria have to be described to evaluate the different properties of nanoplastics. The short article sums up that the development of nanoplastic specific guidelines are crucial and would decrease uncertainties in the risk assessment of nano sized plastics.

Read the complete article here


EUON invites views from different contributors ranging from policy-makers and authorities to industry and civil society on their work and priorities related to nanomaterials on the EU market.

Skip to content